A new department has recently opened at Medisch Spectrum Twente, but this is no ordinary hospital unit. It’s the second Dutch branch of the Center for Human Drug Research (CHDR), an internationally recognized institute specializing in early-phase drug research. Director Rozemarije Holewijn shares why Twente was chosen, the role of technology in their work, and why she believes patient care begins long before the operating room.
Source: Twente.com
-
-
-
-
Delen
The internationally renowned Centre for Human Drug Research (CHDR) opened a new branch at Medisch Spectrum Twente, a major boost for our MedTech ecosystem. CHDR conducts the earliest steps in human drug research using high-tech measurement methods. Twente was chosen for its strong combination of medical expertise, technological innovation, and the close collaboration between MST and the University of Twente.
